JOUNCE THERAPEUTICS INC's ticker is JNCE and the CUSIP is 481116101. A total of 85 filers reported holding JOUNCE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $48,285 | +66.7% | 26,100 | 0.0% | 0.00% | – |
| Q4 2022 | $28,971 | -100.0% | 26,100 | -64.1% | 0.00% | -100.0% |
| Q3 2022 | $85,085,000 | +106256.2% | 72,700 | +177.0% | 0.00% | 0.0% |
| Q2 2022 | $80,000 | -53.8% | 26,250 | +3.1% | 0.00% | -50.0% |
| Q1 2022 | $173,000 | -18.8% | 25,450 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $213,000 | +12.7% | 25,450 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $189,000 | +9.2% | 25,450 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $173,000 | -33.7% | 25,450 | -0.0% | 0.00% | -33.3% |
| Q1 2021 | $261,000 | +9.7% | 25,451 | -28.7% | 0.00% | 0.0% |
| Q4 2020 | $238,000 | -99.9% | 35,700 | +40.3% | 0.00% | -25.0% |
| Q3 2020 | $208,000,000 | – | 25,450 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP II, LLC | 2,697,829 | $20,045,000 | 88.84% |
| TRV GP III, LLC | 3,048,780 | $22,652,000 | 4.30% |
| Logos Global Management LP | 2,000,000 | $14,860,000 | 1.07% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 208,559 | $1,550,000 | 0.88% |
| PFM Health Sciences, LP | 3,848,822 | $28,597,000 | 0.84% |
| Yorktown Management & Research Co Inc | 113,200 | $841,000 | 0.63% |
| Moloney Securities Asset Management, LLC | 282,250 | $2,097,000 | 0.38% |
| PATHWAY CAPITAL MANAGEMENT, LP | 84,763 | $630,000 | 0.30% |
| Sofinnova Investments, Inc. | 637,347 | $4,735,000 | 0.28% |
| Omega Fund Management, LLC | 275,513 | $2,047,000 | 0.23% |